1. Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes?. Issue 11 (3rd June 2013) Authors: Nagendran, J.; Oudit, G. Y.; Bakal, J. A.; Light, P. E.; Dyck, J. R. B.; McAlister, F. A. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 11(2013:Nov.) Page Start: 1022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer. Issue 6 (20th March 2015) Authors: Abdelmoneim, A. S.; Eurich, D. T.; Light, P. E.; Senior, P. A.; Seubert, J. M.; Makowsky, M. J.; Simpson, S. H. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 6(2015:Jun.) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer. Issue 6 (20th March 2015) Authors: Abdelmoneim, A. S.; Eurich, D. T.; Light, P. E.; Senior, P. A.; Seubert, J. M.; Makowsky, M. J.; Simpson, S. H. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 6(2015:Jun.) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Costarting sitagliptin with metformin is associated with a lower likelihood of disease progression in newly treated people with type 2 diabetes: a cohort study. Issue 10 (6th November 2019) Authors: Campbell, S. A.; Light, P. E.; Simpson, S. H. Journal: Diabetic medicine Issue: Volume 37:Issue 10(2020) Page Start: 1715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗